Summary of opinion: Stelara, 26/02/2026 Positive
Submitted by Anonymous (not verified) on 27 February 2026 - 11:00
Summary of opinion: Stelara, 26/02/2026 Positive
Summary of opinion: Dupixent, 26/02/2026 Positive
Submitted by Anonymous (not verified) on 27 February 2026 - 11:00
Summary of opinion: Dupixent, 26/02/2026 Positive
Summary of opinion: Keytruda, 26/02/2026 Positive
Submitted by Anonymous (not verified) on 27 February 2026 - 11:00
Summary of opinion: Keytruda, 26/02/2026 Positive
Info sheet - Orphan medicines in the EU
Submitted by Anonymous (not verified) on 27 February 2026 - 10:58
Info sheet - Orphan medicines in the EU
New medicine to treat paediatric low-grade glioma
Submitted by Anonymous (not verified) on 27 February 2026 - 9:25
New medicine to treat paediatric low-grade glioma
Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures Under evaluation, 27/02/2026
Submitted by Anonymous (not verified) on 27 February 2026 - 9:08
Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures Under evaluation, 27/02/2026
Human medicines European public assessment report (EPAR): Flucelvax Tetra, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 12/12/2018, Revision: 17, Status: Withdrawn
Submitted by Anonymous (not verified) on 27 February 2026 - 9:05
Human medicines European public assessment report (EPAR): Flucelvax Tetra, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 12/12/2018, Revision: 17, Status: Withdrawn
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 20, Status: Authorised
Submitted by Anonymous (not verified) on 26 February 2026 - 16:00
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 26 February 2026 - 15:35
Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised
Submitted by Anonymous (not verified) on 26 February 2026 - 15:32
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised